Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2019 May 2;374:77–85. doi: 10.1016/j.taap.2019.04.025

Fig. 6.

Fig. 6.

SESN2 overexpression reduces tumor cell growth and tumor size.

(A) Western blot analysis and (B) cell survival rate determined by MTT assay for MC38 cells stably expressed SESN2 or EV. (C) Representative images of MC38 tumors and (D) tumor weight at 14 days after subcutaneously injection of MC38 cells. *p < .05 and **p < .01.